Fibrosebiomarkertest

Patent europeic · EP2770327 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2770327
Numer da la dumonda
EP14169636
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
29-03-2010
Publitgà
27-08-2014
Concedì
14-06-2017
Stritgà
31-03-2018
Motiv
Taxa annuala betg pajada
Classas IPC
G01N 33/68 (2006.01)
Prioritad
US 211467 P 30.03.2009
US 289081 P 22.12.2009
Derivà da
EP10715752
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 24-10-2018

    Stritgà, taxa betg pajada

    Published in Swissreg on 24.10.2018

  2. 14-06-2017

    Concedì

    Published in Swissreg on 14.06.2017

Partidas

Possessur

Nordic Bioscience A/S

Herlev Hovedgade 207, 2730 Herlev, DK

Novartis AG

Lichtstrasse 35, 4056 Basel

Inventur

Veidal, Sanne S.

3650 Olstykke, DK

Karsdal, Morten A.

2100 Copenhagen, DK

Leeming, Diana J.

2450 Copenhagen SV, DK

Barascuk, Natasha

2100 Copenhagen, DK

Skjot-Arkil, Helene

2300 Copenhagen, DK

Segovia-Silvestre, Antonio

2200 Copenhagen, DK

Vassiliadis, Efstathios

2610 Rødovre, DK

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.